c. drissi, i. kraoua *, i. rebaï *, s. nagi , n. gouider - khouja *, m. ben hamouda

24
Imaging and clinical features of metachromatic leukodystrophy: a study in 9 Tunisian children C. Drissi, I. Kraoua*, I. Rebaï*, S. Nagi, N. Gouider-Khouja*, M. Ben Hamouda Neuroradiology and * * Pediatric Neurology Departments –National Institute of Neurology – Tunis – Tunisia PEDIATRICS : PD 19

Upload: ramla

Post on 24-Feb-2016

21 views

Category:

Documents


0 download

DESCRIPTION

Imaging and clinical features of metachromatic leukodystrophy : a study in 9 Tunisian children. C. Drissi, I. Kraoua *, I. Rebaï *, S. Nagi , N. Gouider - Khouja *, M. Ben Hamouda - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: C. Drissi, I.  Kraoua *, I.  Rebaï *, S.  Nagi , N.  Gouider - Khouja *, M. Ben  Hamouda

Imaging and clinical features of metachromatic leukodystrophy:

a study in 9 Tunisian children

C. Drissi, I. Kraoua*, I. Rebaï*, S. Nagi, N. Gouider-Khouja*, M. Ben HamoudaNeuroradiology and * * Pediatric Neurology Departments –National Institute of Neurology – Tunis – Tunisia PEDIATRICS : PD 19

Page 2: C. Drissi, I.  Kraoua *, I.  Rebaï *, S.  Nagi , N.  Gouider - Khouja *, M. Ben  Hamouda

Introduction

•  Metachromatic leucodystrophy (MLD) is an autosomal recessive lysosomal disorder caused by deficiency of arylsulfatase A activity resulting in demyelination within the central and peripheral nervous system.

• 3 clinical forms: – Late-infantile (<3 years)– Juvenile (<16 years)– Adult (>16 ans)

Costello et al ,2009

Page 3: C. Drissi, I.  Kraoua *, I.  Rebaï *, S.  Nagi , N.  Gouider - Khouja *, M. Ben  Hamouda

Objective

• The aim of this study is to describe the imaging and clinical features of MLD in 9 Tunisian children.

• The results are analyzed and discussed with a literature review.

Page 4: C. Drissi, I.  Kraoua *, I.  Rebaï *, S.  Nagi , N.  Gouider - Khouja *, M. Ben  Hamouda

• Retrospective study (2005-2011)• 9 children from 8 families with confirmed MLD • Followed in the department of Pediatric Neurology at

the National Institute of Neurology of Tunis • Brain MRI was performed in all cases• Imaging and Clinical data are analyzed

Patients and methods

Page 5: C. Drissi, I.  Kraoua *, I.  Rebaï *, S.  Nagi , N.  Gouider - Khouja *, M. Ben  Hamouda

Results

• 9 children : 2 / 7 ♂ ♀

• Mean age: 32 months (17 months – 6 years)

• 8 patients with late infantile MLD with a mean age at onset of 16 months

• One patient with a juvenile form with age at onset of 4 years

Page 6: C. Drissi, I.  Kraoua *, I.  Rebaï *, S.  Nagi , N.  Gouider - Khouja *, M. Ben  Hamouda

8/9

7/9

Results

Page 7: C. Drissi, I.  Kraoua *, I.  Rebaï *, S.  Nagi , N.  Gouider - Khouja *, M. Ben  Hamouda

• Psychomotor regression: 8/9• Irritability : 8/9• Epilepsy : 3/9 (uncontrolled in one case)• Learning disabilities and gait disturbance: 1 case

(juvenile form)

Results

Clinical presentation

Page 8: C. Drissi, I.  Kraoua *, I.  Rebaï *, S.  Nagi , N.  Gouider - Khouja *, M. Ben  Hamouda

0

2

4

6

8

10

12

Typical signs

Atypical signs

Results

Examination 

Page 9: C. Drissi, I.  Kraoua *, I.  Rebaï *, S.  Nagi , N.  Gouider - Khouja *, M. Ben  Hamouda

Results

• Brain MRI showed bilateral symmetric areas of T2 hyperintensity involving supra-tentorial deep white matter in 8 cases, sparing U fibers in most cases (6/8).

• In all of these 8 cases, a pattern of radial stripes was seen.

• In 2 cases, it also involved cerebellar white matter, the posterior limb of the internal capsule and the pyramidal tract within the crus cerebri.

MRI

Page 10: C. Drissi, I.  Kraoua *, I.  Rebaï *, S.  Nagi , N.  Gouider - Khouja *, M. Ben  Hamouda

T2 hyperintensity of the supratentorial white matter, and displaying the radial stripes pattern

U fibers spared U fibers involved

Page 11: C. Drissi, I.  Kraoua *, I.  Rebaï *, S.  Nagi , N.  Gouider - Khouja *, M. Ben  Hamouda

T2 hyperintensity of the posterior limb of the internal capsule

and the pyramidal tract within the crus cerebriT2 hyperintensity of the cerebellar white matter,

Page 12: C. Drissi, I.  Kraoua *, I.  Rebaï *, S.  Nagi , N.  Gouider - Khouja *, M. Ben  Hamouda

Results

• Corpus callosum was involved in all cases, atrophic in one case and presenting with a hyperintensity in all other 8 cases.

• The hyperintensity involved the splenium in 5 cases, the genu in 1 case and the entire corpus callosum in 1 case.

• Severe cortical atrophy was seen in one case.

MRI

Page 13: C. Drissi, I.  Kraoua *, I.  Rebaï *, S.  Nagi , N.  Gouider - Khouja *, M. Ben  Hamouda

Corpus callosum involvement

genu T2 hyperintensitysplenium T2 hyperintensity

atrophy

Page 14: C. Drissi, I.  Kraoua *, I.  Rebaï *, S.  Nagi , N.  Gouider - Khouja *, M. Ben  Hamouda

Results

• CSF analysis : hyperproteinorachia: 9/9

• NCV Studies: demyelinating neuropathy: 9/9

• Arylsulfatase A activity : very low : 8/8

Investigations 

Page 15: C. Drissi, I.  Kraoua *, I.  Rebaï *, S.  Nagi , N.  Gouider - Khouja *, M. Ben  Hamouda

Metachromatic leukodystrophy MLD

• Incidence 0.6 – 1.85 / 100.000 live birth

• Pathophysiology3-O-sulfogalactosylceramide galactosylceramide

• Sulfatides accumulation and oligodendrocytes death• Demyelination of central and peripheral nervous system

Arylsulfatase A (ASA)

X(sulfatide)

Arvan et al, 2011

Page 16: C. Drissi, I.  Kraoua *, I.  Rebaï *, S.  Nagi , N.  Gouider - Khouja *, M. Ben  Hamouda

MLD

3 clinical forms 

Clinical form Late infantile Juvenile Adult

Age at onsetyeras

2nd  year(< 3 )

3 – 16  > 16

Presentation Psychomotor regression, irritability

Learning disabilities, behavior disorders

Dementia« schizophrenia »

Examination Pyramidal signs, hypertonia, abolished deep tendon reflexes, optic atrophy

Pyramidal signs, ataxia dementia

Outcome death

2 – 6 years 10 – 20 years 30 ans

Arvan et al, 2011

Page 17: C. Drissi, I.  Kraoua *, I.  Rebaï *, S.  Nagi , N.  Gouider - Khouja *, M. Ben  Hamouda

MLD

MRI• Periventricular WM abnormalities,with a more or

less symmetrical distribution. • The white matter lesions are highly confluent.• In later onset cases involvement is often

predominantly frontal, whereas in early-onset cases occipital predominance can be observed.

• The arcuate fibers are relatively spared, but become involved in the later stages.

Page 18: C. Drissi, I.  Kraoua *, I.  Rebaï *, S.  Nagi , N.  Gouider - Khouja *, M. Ben  Hamouda

MLD

MRI

Typically a pattern of radiating stripes– lysosomal storage disorders

(Krabbe, GM1)– relative myelin sparing?– lipid storage?

Van der Voorn et al, AJNR, 2005

Page 19: C. Drissi, I.  Kraoua *, I.  Rebaï *, S.  Nagi , N.  Gouider - Khouja *, M. Ben  Hamouda

MLD

• Probably the first abnormalities to be noted on MRI are in the corpus callosum (CC).

• CC is always affected, connecting the lesions from both sides.

MRI

T2 hyperintensity of the splenium of the CC in the unique case without involvement of WM

Page 20: C. Drissi, I.  Kraoua *, I.  Rebaï *, S.  Nagi , N.  Gouider - Khouja *, M. Ben  Hamouda

MLD

MRI

• Cerebral WM atrophy occurs in advanced stages. • Some patients show bilateral involvement of :– the posterior limb of the internal capsule,– the cerebellar white matter,– pyramidal tracts in the brain stem, especially in the more

advanced cases. • No contrast enhancement is seen.• A MR severity scoring method has been proposed by

Eichler et al.Eichler F et al, AJNR, 2009

Page 21: C. Drissi, I.  Kraoua *, I.  Rebaï *, S.  Nagi , N.  Gouider - Khouja *, M. Ben  Hamouda

MLD

MRI

• Diffusion weighted-imaging :– Hyperintensity with low ADC values

in deep white matter• MR-Spectroscopy:– decreased choline peak– Myoinositol peak– Lactates

Sener RN,AJNR, 2002Sener RN, Acta Radiologica 2003

Page 22: C. Drissi, I.  Kraoua *, I.  Rebaï *, S.  Nagi , N.  Gouider - Khouja *, M. Ben  Hamouda

MLD

CSF : hyperproteinorachia

NCV studies : demyelinating neuropathy

Biochemical diagnosis : ASA activity+++

Molecular  diagnosis: 22q13.3-qter, ARSA gene > 100 mutations Genotype / phenotype correlation

Diagnosis 

Groeschel et al, 2011

Page 23: C. Drissi, I.  Kraoua *, I.  Rebaï *, S.  Nagi , N.  Gouider - Khouja *, M. Ben  Hamouda

MLD

• Symptomatic forms: symptomatic treatment

• Presymptomatic forms:

Hematopoietic stem cell transplantation

Clinical research: gene therapy, enzyme replacement therapy

• Genetic counselling

Treatment

Batzios et al, 2012; Biffi et al, 2011Gieselmann et al, 2011

Arvan et al, 2011

Page 24: C. Drissi, I.  Kraoua *, I.  Rebaï *, S.  Nagi , N.  Gouider - Khouja *, M. Ben  Hamouda

Conclusions

• Imaging features in MLD are non specific but can be highly suggestive in children presenting with psychomotor regression

• The diagnosis, confirmed by specific biological tests, allows genetic counseling